Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database

Fayçal Ben Bouallègue (1, 2) , Denis Mariano-Goulart (2, 1) , Pierre Payoux (3, 4)

1 PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046]
2 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
3 Service de Médecine Nucléaire - Pierre-Paul Riquet [CHU Toulouse]
4 ToNIC - Toulouse NeuroImaging Center

Mots clés: Alzheimer Disease; France; 80 and over; Peptide Fragments; Male; Biomarkers; MCI; Comorbidity; Risk Assessment; Aged; Sensitivity and Specificity; Factual; Middle Aged; Amyloid PET; Databases; Differential; Humans; Reproducibility of Results; Diagnosis; tau Proteins; ADNI; Radiopharmaceuticals; Cognition Disorders; Prognosis; Amyloid beta-Peptides; CSF markers; Alzheimer\textquoterights disease; Female; Prevalence; Positron-Emission Tomography

Domaines: Sciences du Vivant [q-bio]

Fayçal Ben Bouallègue, Denis Mariano-Goulart, Pierre Payoux. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database. Alzheimer's Research and Therapy, 2017, 9 (1), pp.32. ⟨10.1186/s13195-017-0260-z⟩. ⟨hal-01792572⟩